Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-Resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meet

Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs

Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer

Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference